Drug delivery in degenerative joint disease: Where we are and where to go?☆

    loading  Checking for direct PDF access through Ovid

Abstract

Drug discovery and delivery to retard the degeneration of joint tissues are challenging. Current treatment is generally inadequate. This commentary places in perspective the inadequacy characteristic of existing therapeutics and the promising developments embodied in the newer therapeutics administered via the oral or intra-auricular routes.

Related Topics

    loading  Loading Related Articles